Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis

Published:2019-08 Issue:3 Volume:200 Page:336-347
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Newton Chad A.¹,Zhang David¹²^ORCID,Oldham Justin M.³,Kozlitina Julia²,Ma Shwu-Fan⁴,Martinez Fernando J.⁵,Raghu Ganesh⁶,Noth Imre⁴,Garcia Christine Kim¹²

Affiliation:

1. Department of Medicine and

2. Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, Texas

3. Department of Medicine, University of California at Davis, Davis, California

4. Department of Medicine, University of Virginia, Charlottesville, Virginia

5. Department of Medicine, Weill Cornell Medical Center, New York, New York; and

6. Department of Medicine, University of Washington Medical Center, Seattle, Washington

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201809-1646OC

Reference50 articles.

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

2. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

3. Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

4. Adult-onset pulmonary fibrosis caused by mutations in telomerase

5. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-08-15

2. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts;American Journal of Respiratory and Critical Care Medicine;2024-08-15

3. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions;American Journal of Respiratory and Critical Care Medicine;2024-08-15

4. Use of peptide nucleic acid probe to determine telomere dynamics in improving chromosome analysis in genetic toxicology studies;Mutation Research - Genetic Toxicology and Environmental Mutagenesis;2024-07

5. Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease;Biomedicines;2024-06-21